NCT00206687 - STEPS Trial - Spheramine Safety and Efficacy Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 8, 2003

Primary Completion Date

May 14, 2012

Study Completion Date

May 14, 2012

Conditions

Parkinson Disease

Interventions

BIOLOGICAL

Spheramine (BAY86-5280)

Bilateral implantation of Spheramine into the postcommissural putamen, each side at a dose of 325,000 cells

PROCEDURE

Placebo

Sham surgery procedure without penetration of the dura mater. Nothing wil be implanted into the brain.

Trial Locations (15)

19107

Philadelphia

22307

Hamburg

30329

Atlanta

33606

Tampa

35039

Marburg

35233

Birmingham

60612

Chicago

66160

Kansas City

66424

Homburg

77030

Houston

90095

Los Angeles

02118

Boston

10029-6574

New York

01307

Dresden

08036

Barcelona